Arvinas (ARVN) Cash & Equivalents Growth (3y) (2020 - 2026)
Arvinas (ARVN) Cash & Equivalents Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
24.73% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
21.66% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-12.47% |
| Date | Value |
|---|
| Mar 31, 2026 |
-12.47% |
| Dec 31, 2025 |
20.68% |
| Sep 30, 2025 |
-8.52% |
| Jun 30, 2025 |
7.23% |
| Mar 31, 2025 |
9.14% |
| Dec 31, 2024 |
-2.46% |
| Sep 30, 2024 |
-30.67% |
| Jun 30, 2024 |
47.01% |
| Mar 31, 2024 |
-36.65% |
| Dec 31, 2023 |
-19.09% |
| Sep 30, 2023 |
8.51% |
| Jun 30, 2023 |
61.29% |
| Mar 31, 2023 |
53.35% |
| Dec 31, 2022 |
106.66% |
| Sep 30, 2022 |
121.90% |
| Jun 30, 2022 |
101.79% |
| Mar 31, 2022 |
29.35% |
| Dec 31, 2021 |
223.80% |
| Sep 30, 2021 |
245.65% |
| Dec 31, 2020 |
167.00% |
